{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:52:05Z","timestamp":1790394725240,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY13574"],"award-info":[{"award-number":["EY13574"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK35124"],"award-info":[{"award-number":["DK35124"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK72517"],"award-info":[{"award-number":["DK72517"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["EB00415"],"award-info":[{"award-number":["EB00415"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008087","name":"Guthy-Jackson Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40478-017-0417-9","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T15:00:45Z","timestamp":1487343645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G"],"prefix":"10.1186","volume":"5","author":[{"given":"Xiaoming","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","volume":"127","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Ratelade J, Verkman AS (2014) Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG. Acta Neuropathol 127:539\u2013551","journal-title":"Acta Neuropathol"},{"key":"417_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/2051-5960-2-48","volume":"2","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Verkman AS (2014) Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol Commun 2:48","journal-title":"Acta Neuropathol Commun"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2012.09.010","volume":"254","author":"N Asgari","year":"2013","unstructured":"Asgari N, Khorooshi R, Lillevang ST, Owens T (2013) Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid. J Neuroimmunol 254:76\u201382","journal-title":"J Neuroimmunol"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617\u2013629","journal-title":"Ann Neurol"},{"key":"417_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s002620000120","volume":"49","author":"I Bergman","year":"2000","unstructured":"Bergman I, Basse PH, Barmada MA, Griffin JA, Cheung NK (2000) Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. Cancer Immunol Immunother 49:259\u2013266","journal-title":"Cancer Immunol Immunother"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","volume":"126","author":"RA Brodsky","year":"2015","unstructured":"Brodsky RA (2015) Complement in hemolytic anemia. Blood 126:2459\u20132465","journal-title":"Blood"},{"key":"417_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12974-016-0746-9","volume":"13","author":"CM Felix","year":"2016","unstructured":"Felix CM, Levin MH, Verkman AS (2016) Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G. J Neuroinflammation 13:275","journal-title":"J Neuroinflammation"},{"key":"417_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2011.02.018","volume":"306","author":"K Fujihara","year":"2011","unstructured":"Fujihara K (2011) Neuromyelitis optica and astrocytic damage in its pathogenesis. Journal of neurological sciences 306:183\u2013187","journal-title":"Journal of neurological sciences"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2014.12.015","volume":"265","author":"C Geis","year":"2015","unstructured":"Geis C, Ritter C, Ruschil C, Weishaupt A, Grunewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV (2015) The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model. Exp Neurol 265:8\u201321","journal-title":"Exp Neurol"},{"key":"417_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1352458506070145","volume":"13","author":"GJ Hengstman","year":"2007","unstructured":"Hengstman GJ, Wesseling P, Frenken CW, Jongen PJ (2007) Neuromyelitis optica with clinical and histopathological involvement of the brain. Mult Scler 13:679\u2013682","journal-title":"Mult Scler"},{"key":"417_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molimm.2004.03.012","volume":"41","author":"VM Holers","year":"2004","unstructured":"Holers VM, Thurman JM (2004) The alternative pathway of complement in disease:opportunities for therapeutic targeting. Mol Immunol 41:147\u2013152","journal-title":"Mol Immunol"},{"key":"417_CR12","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V85.8.2228.bloodjournal8582228","volume":"85","author":"N Iwamoto","year":"1995","unstructured":"Iwamoto N, Kawaguchi T, Nagakura S, Hidaka M, Horikawa K, Kagimoto T, Takatsuki K, Nakakuma H (1995) Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria. Blood 85:2228\u20132232","journal-title":"Blood"},{"key":"417_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383\u2013392","journal-title":"Nat Rev Neurol"},{"key":"417_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477","journal-title":"J. Exp. Med."},{"key":"417_CR15","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1096\/fj.10-177279","volume":"25","author":"L Li","year":"2011","unstructured":"Li L, Zhang H, Varrin-Doyer M, Zamvil SS, Verkman AS (2011) Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation. FASEB J 25:1556\u20131566","journal-title":"FASEB J."},{"key":"417_CR16","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"417_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12974-016-0577-8","volume":"13","author":"R Marignier","year":"2016","unstructured":"Marignier R, Ruiz A, Cavagna S, Nicole A, Watrin C, Touret M, Parrot S, Malleret G, Peyron C, Benetollo C, Auvergnon N, Vukusic S, Giraudon P (2016) Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid. J Neuroinflammation 13:111","journal-title":"J Neuroinflammation"},{"key":"417_CR18","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130:1224\u20131234","journal-title":"Brain"},{"key":"417_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS (2012) Aquaporin 4 and neuromyelitis optica. The Lancet Neurology 11:535\u2013544","journal-title":"The Lancet Neurology"},{"key":"417_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1742-2094-7-60","volume":"7","author":"BG Perez-Nievas","year":"2010","unstructured":"Perez-Nievas BG, Garcia-Bueno B, Madrigal JL, Leza JC (2010) Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. J Neuroinflammation 7:60","journal-title":"J Neuroinflammation"},{"key":"417_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","volume":"12","author":"SJ Pittock","year":"2013","unstructured":"Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O\u2019Toole O, Wingerchuk DM (2013) Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. The Lancet Neurology 12:554\u2013562","journal-title":"The Lancet Neurology"},{"key":"417_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-011-0824-0","volume":"122","author":"M Pohl","year":"2011","unstructured":"Pohl M, Fischer MT, Mader S, Schanda K, Kitic M, Sharma R, Wimmer I, Misu T, Fujihara K, Reindl M, Lassmann H, Bradl M (2011) Pathogenic T cell responses against aquaporin 4. Acta Neuropathol 122:21\u201334","journal-title":"Acta Neuropathol"},{"key":"417_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1074-7613(03)00022-0","volume":"18","author":"X Qin","year":"2003","unstructured":"Qin X, Krumrei N, Grubissich L, Dobarro M, Aktas H, Perez G, Halperin JA (2003) Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility. Immunity 18:217\u2013227","journal-title":"Immunity"},{"key":"417_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","volume":"126","author":"J Ratelade","year":"2013","unstructured":"Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS (2013) Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol 126:699\u2013709","journal-title":"Acta Neuropathol"},{"key":"417_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.molimm.2014.06.003","volume":"62","author":"J Ratelade","year":"2014","unstructured":"Ratelade J, Verkman AS (2014) Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica. Mol Immunol 62:104\u2013113","journal-title":"Mol Immunol"},{"key":"417_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194\u20131205","journal-title":"Brain"},{"key":"417_CR27","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1177\/1352458515571446","volume":"21","author":"S Saadoun","year":"2015","unstructured":"Saadoun S, Papadopoulos MC (2015) Role of membrane complement regulators in neuromyelitis optica. Mult Scler 21:1644\u20131654","journal-title":"Mult Scler"},{"key":"417_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133:349\u2013361","journal-title":"Brain"},{"key":"417_CR29","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.bpj.2015.10.047","volume":"109","author":"AJ Smith","year":"2015","unstructured":"Smith AJ, Verkman AS (2015) Superresolution imaging of aquaporin-4 cluster size in antibody-stained paraffin brain sections. Biophys J 109:2511\u20132522","journal-title":"Biophys J"},{"key":"417_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ana.23741","volume":"73","author":"L Tradtrantip","year":"2013","unstructured":"Tradtrantip L, Ratelade J, Zhang H, Verkman AS (2013) Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol 73:77\u201385","journal-title":"Ann Neurol"},{"key":"417_CR31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/jcp.2008.056317","volume":"61","author":"DJ Unsworth","year":"2008","unstructured":"Unsworth DJ (2008) Complement deficiency and disease. J Clin Pathol 61:1013\u20131017","journal-title":"J Clin Pathol"},{"key":"417_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0022-1759(91)90015-8","volume":"136","author":"CW Van den Berg","year":"1991","unstructured":"Van den Berg CW, Aerts PC, Van Dijk H (1991) In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J Immunol Methods 136:287\u2013294","journal-title":"J Immunol Methods"},{"key":"417_CR33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.toxicon.2010.04.007","volume":"56","author":"CW Vogel","year":"2010","unstructured":"Vogel CW, Fritzinger DC (2010) Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion. Toxicon 56:1198\u20131222","journal-title":"Toxicon"},{"key":"417_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-016-0309-4","volume":"4","author":"X Yao","year":"2016","unstructured":"Yao X, Su T, Verkman AS (2016) Clobetasol promotes remyelination in a mouse model of neuromyelitis optica. Acta Neuropathol Commun 4:42","journal-title":"Acta Neuropathol Commun"},{"key":"417_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00401-015-1501-5","volume":"130","author":"B Zeka","year":"2015","unstructured":"Zeka B, Hastermann M, Hochmeister S, Kogl N, Kaufmann N, Schanda K, Mader S, Misu T, Rommer P, Fujihara K, Illes Z, Leutmezer F, Sato DK, Nakashima I, Reindl M, Lassmann H, Bradl M (2015) Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathol 130:783\u2013798","journal-title":"Acta Neuropathol"},{"key":"417_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40478-016-0355-y","volume":"4","author":"B Zeka","year":"2016","unstructured":"Zeka B, Hastermann M, Kaufmann N, Schanda K, Pende M, Misu T, Rommer P, Fujihara K, Nakashima I, Dahle C, Leutmezer F, Reindl M, Lassmann H, Bradl M (2016) Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO\/SD. Acta Neuropathol Commun 4:82","journal-title":"Acta Neuropathol Commun"},{"key":"417_CR37","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1172\/JCI67554","volume":"123","author":"H Zhang","year":"2013","unstructured":"Zhang H, Verkman AS (2013) Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica. J Clin Invest 123:2306\u20132316","journal-title":"J Clin Invest"},{"key":"417_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","volume":"53","author":"H Zhang","year":"2014","unstructured":"Zhang H, Verkman AS (2014) Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun 53:67\u201377","journal-title":"J Autoimmun"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-017-0417-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:56:08Z","timestamp":1589554568000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-017-0417-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1186\/s40478-017-0417-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]},"assertion":[{"value":"29 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}